We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$311B
AUM Growth
+$27B
Cap. Flow
-$2.73B
Cap. Flow %
-0.88%
Top 10 Hldgs %
26.14%
Holding
3,413
New
219
Increased
1,869
Reduced
1,057
Closed
98

Top Buys

Rank Stock Value
1
CRH icon
CRH
CRH
+$482M
2
SHOP icon
Shopify
SHOP
+$353M
3
INTC icon
Intel
INTC
+$318M
4
NKE icon
Nike
NKE
+$312M
5
UBS icon
UBS Group
UBS
+$309M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$520M
2
ORCL icon
Oracle
ORCL
+$471M
3
CRM icon
Salesforce
CRM
+$452M
4
EOG icon
EOG Resources
EOG
+$360M
5
META icon
Meta Platforms (Facebook)
META
+$246M

Sector Composition

Rank Sector Weight
1 Technology 28.65%
2 Financials 12.19%
3 Healthcare 11.7%
4 Consumer Discretionary 11.15%
5 Industrials 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSV icon
2026
Carriage Services
CSV
$569M
$4.6M ﹤0.01%
183,811
+8
+0% +$188
TWO
2027
Two Harbors Investment
TWO
$1.27B
$4.59M ﹤0.01%
329,197
+93,694
+40% +$1.21M
EBF icon
2028
Ennis
EBF
$564M
$4.57M ﹤0.01%
208,798
+209
+0.1% +$4.5K
WMK icon
2029
Weis Markets
WMK
$1.86B
$4.55M ﹤0.01%
71,077
+10,947
+18% +$697K
CPRX
2030
DELISTED
Catalyst Pharmaceutical
CPRX
$4.52M ﹤0.01%
268,712
+4,877
+2% +$66.7K
OCUL icon
2031
Ocular Therapeutix
OCUL
$2.02B
$4.52M ﹤0.01%
1,012,543
+1,505
+0.1% +$4.45K
ICUI icon
2032
ICU Medical
ICUI
$4.61B
$4.51M ﹤0.01%
45,197
+247
+0.5% +$24.2K
MBB icon
2033
iShares MBS ETF
MBB
$39.1B
$4.51M ﹤0.01%
+47,898
New +$4.3M
TALO icon
2034
Talos Energy
TALO
$2.4B
$4.49M ﹤0.01%
315,601
+3,816
+1% +$55.8K
GEF icon
2035
Greif
GEF
$5.04B
$4.49M ﹤0.01%
68,384
+262
+0.4% +$17.3K
EMBC icon
2036
Embecta
EMBC
$262M
$4.49M ﹤0.01%
236,927
+13,672
+6% +$224K
CLNE icon
2037
Clean Energy Fuels
CLNE
$347M
$4.48M ﹤0.01%
1,170,831
+51,933
+5% +$189K
GIL icon
2038
Gildan
GIL
$10.6B
$4.45M ﹤0.01%
+133,870
New +$4.34M
TROX icon
2039
Tronox
TROX
$1.04B
$4.44M ﹤0.01%
313,674
+5,556
+2% +$68.2K
RNAM
2040
DELISTED
Avidity Biosciences
RNAM
$4.44M ﹤0.01%
490,594
+279,718
+133% +$1.87M
DRS icon
2041
Leonardo DRS
DRS
$12B
$4.44M ﹤0.01%
221,342
+23,016
+12% +$434K
ERII icon
2042
Energy Recovery
ERII
$443M
$4.41M ﹤0.01%
234,288
-573
-0.2% -$10.6K
GTES icon
2043
Gates Industrial Corporation Ltd.
GTES
$7.15B
$4.41M ﹤0.01%
328,248
-7,475
-2% -$88.4K
ING icon
2044
ING
ING
$102B
$4.4M ﹤0.01%
293,079
+289,375
+7,813% +$3.98M
LESL icon
2045
Leslie's
LESL
$11M
$4.4M ﹤0.01%
31,812
-397
-1% -$43.7K
DDS icon
2046
Dillards
DDS
$9.56B
$4.38M ﹤0.01%
10,846
+1,708
+19% +$579K
PAX icon
2047
Patria Investments
PAX
$1.86B
$4.38M ﹤0.01%
282,199
+59,727
+27% +$848K
CAKE icon
2048
Cheesecake Factory
CAKE
$5.33B
$4.37M ﹤0.01%
124,781
+1,070
+0.9% +$34.2K
AMWD
2049
DELISTED
American Woodmark
AMWD
$4.36M ﹤0.01%
46,994
+766
+2% +$59.7K
AIV
2050
Aimco
AIV
$383M
$4.36M ﹤0.01%
556,634
+61
+0% +$412

Similar funds

Nuveen's Q4 2023 Portfolio in Review

As of Q4 2023, Nuveen held 3,413 positions worth $311B, up 9.5% from $284B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Nuveen's Q4 2023 filing shows 219 new, 1,869 increased, 1,057 reduced and 98 closed positions. Its largest new stake was CRH: 7,989,897 shares worth $552M. The largest sale was Amazon, an estimated $520M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q4 2023 buy was CRH: 7,989,897 shares worth $552M.
  • Nuveen added most to Intel in Q4 2023, an estimated $318M increase.
  • Nuveen's biggest Q4 2023 reduction was Amazon, cutting an estimated $520M.
  • Nuveen fully exited Activision Blizzard in Q4 2023, selling an estimated $194M.
  • Nuveen's ten largest holdings make up 26% of its $311B portfolio in Q4 2023.
  • Nuveen opened 219 new positions and closed 98 in Q4 2023.
  • Nuveen's portfolio value rose 9.5% quarter-over-quarter to $311B.

Based on Nuveen's 13F filing for Q4 2023, filed 14 Feb 2024.